Yasho Industries Ltd. (IN:YASHO)
:YASHO
Want to see IN:YASHO full AI Analyst Report?
Top Page
Yasho Industries Ltd.
(YASHO)
Select Model
Select Model
Rating:52Neutral
Price Target:
₹1,554.00
▲(8.15% Upside)
Action:Reiterated
Date:02/04/26
The score is held back mainly by profitability and cash-flow weakness alongside elevated leverage, despite solid revenue growth and healthy operating margins. Technicals are also soft (negative MACD and trading below key longer-term moving averages), and valuation is a major headwind due to a very high P/E.
Positive Factors
Revenue Growth
Sustained revenue growth (~16.6% reported) indicates expanding product adoption and market penetration across end markets. Over the next 2–6 months this revenue traction supports scale benefits, resilience to single-market shocks, and provides a foundation for reinvesting in specialty grades and capacity.
Negative Factors
Net Profit Margin Deterioration
A sharp decline in net income and resulting compressed net margins reduces retained earnings and the firm’s ability to self-fund growth. Persistently lower net profitability can force trade-offs on capex, R&D or pricing strategy and elevate vulnerability to commodity-cost swings or customer price pressure.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained revenue growth (~16.6% reported) indicates expanding product adoption and market penetration across end markets. Over the next 2–6 months this revenue traction supports scale benefits, resilience to single-market shocks, and provides a foundation for reinvesting in specialty grades and capacity.
Read all positive factors
Yasho Industries Ltd. (YASHO) vs. iShares MSCI India ETF (INDA)
Market Cap
₹24.77B
Dividend Yield0.03%
Average Volume (3M)1.03K
Price to Earnings (P/E)95.3
Beta (1Y)0.59
Revenue Growth24.16%
EPS Growth309.24%
CountryIN
Employees818
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)10.71
Shares Outstanding12,057,095
10 Day Avg. Volume567
30 Day Avg. Volume1,032
Financial Highlights & Ratios
PEG Ratio-3.67
Price to Book (P/B)4.78
Price to Sales (P/S)3.00
P/FCF Ratio-44.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Yasho Industries Ltd. Business Overview & Revenue Model
Company Description
Yasho Industries Limited manufactures and supplies specialty chemicals, food antioxidants, aroma chemicals, rubber chemicals, and lubricant additives in the United States, Europe, Asia, and the Middle East. The company offers various chemicals, su...
How the Company Makes Money
Yasho Industries makes money primarily by manufacturing specialty chemical products and selling them to business customers (B2B). Its core revenue stream is product sales: it produces performance chemicals (e.g., additives/ingredients and intermed...
Yasho Industries Ltd. Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
60
Neutral
Cash Flow
55
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.14B | 6.68B | 5.94B | 6.68B | 6.08B | 3.58B |
| Gross Profit | 2.71B | 2.78B | 2.07B | 2.49B | 2.18B | 1.21B |
| EBITDA | 1.27B | 1.10B | 1.07B | 1.24B | 1.03B | 590.86M |
| Net Income | 127.12M | 61.10M | 579.37M | 678.68M | 522.86M | 214.77M |
Balance Sheet | ||||||
| Total Assets | 11.30B | 10.94B | 9.93B | 6.50B | 4.83B | 3.05B |
| Cash, Cash Equivalents and Short-Term Investments | 168.67M | 284.30M | 988.00K | 5.20M | 2.19M | 6.49M |
| Total Debt | 5.91B | 5.83B | 5.79B | 3.24B | 1.79B | 1.64B |
| Total Liabilities | 7.02B | 6.74B | 6.98B | 4.12B | 3.10B | 2.26B |
| Stockholders Equity | 4.28B | 4.20B | 2.95B | 2.38B | 1.73B | 789.31M |
Cash Flow | ||||||
| Free Cash Flow | 198.66M | -454.10M | -2.47B | -1.41B | -444.36M | 206.34M |
| Operating Cash Flow | 617.86M | -419.70M | 901.86M | 125.20M | 161.59M | 346.27M |
| Investing Cash Flow | -446.42M | -87.60M | -3.04B | -1.32B | -591.65M | -135.55M |
| Financing Cash Flow | -207.97M | 592.20M | 2.14B | 1.22B | 426.12M | -209.44M |
Yasho Industries Ltd. Technical Analysis
Positive
1436.90
Price Trends
1498.59
Positive
1440.42
Positive
1563.52
Positive
Market Momentum
98.80
Negative
81.81
Negative
85.52
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:YASHO, the sentiment is Positive. The current price of 1436.9 is below the 20-day moving average (MA) of 1597.64, below the 50-day MA of 1498.59, and below the 200-day MA of 1563.52, indicating a bullish trend. The MACD of 98.80 indicates Negative momentum. The RSI at 81.81 is Negative, neither overbought nor oversold. The STOCH value of 85.52 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:YASHO.
Yasho Industries Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₹39.74B | 17.65 | ― | 0.65% | 44.79% | 14.20% | |
65 Neutral | ₹11.65B | 17.66 | ― | 0.52% | 21.13% | 18.86% | |
63 Neutral | ₹12.50B | 17.11 | ― | 0.24% | 14.36% | 64.31% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ₹35.09B | 29.38 | ― | 0.97% | 8.37% | 19.15% | |
53 Neutral | ₹29.06B | 51.39 | ― | 0.07% | 32.18% | 636.02% | |
52 Neutral | ₹24.77B | 95.28 | ― | 0.03% | 24.16% | 309.24% |
* Basic Materials Sector Average
IN:YASHO
Yasho Industries Ltd.
2,054.45
301.74
17.22%
IN:FCL
Fineotex Chemical Limited
34.13
11.05
47.88%
IN:IOLCP
IOL Chemicals & Pharmaceuticals Ltd.
119.54
34.47
40.52%
IN:PUNJABCHEM
Punjab Chemicals & Crop Protection Ltd.
1,019.60
-94.17
-8.46%
IN:SHREEPUSHK
Shree Pushkar Chemicals & Fertilisers Ltd.
360.30
68.05
23.28%
IN:TATVA
Tatva Chintan Pharma Chem Limited
1,242.45
276.81
28.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.